Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Free Cash Flow (2016 - 2026)

Intellia Therapeutics has reported Free Cash Flow over the past 12 years, most recently at -$117.4 million for Q1 2026.

  • Quarterly Free Cash Flow rose 21.2% to -$117.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$363.2 million through Mar 2026, up 3.23% year-over-year, with the annual reading at -$394.8 million for FY2025, 12.97% down from the prior year.
  • Free Cash Flow was -$117.4 million for Q1 2026 at Intellia Therapeutics, down from -$69.3 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$56.3 million in Q2 2024 and troughed at -$149.0 million in Q1 2025.
  • The 5-year median for Free Cash Flow is -$93.0 million (2023), against an average of -$94.4 million.
  • Year-over-year, Free Cash Flow surged 40.49% in 2024 and then plummeted 76.77% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$93.8 million in 2022, then grew by 0.8% to -$93.0 million in 2023, then grew by 12.96% to -$81.0 million in 2024, then rose by 14.4% to -$69.3 million in 2025, then tumbled by 69.4% to -$117.4 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Free Cash Flow are -$117.4 million (Q1 2026), -$69.3 million (Q4 2025), and -$76.9 million (Q3 2025).